These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20552571)

  • 1. A consistency-adjusted alpha-adaptive strategy for sequential testing.
    Alosh M; Huque MF
    Stat Med; 2010 Jul; 29(15):1559-71. PubMed ID: 20552571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A consistency-adjusted strategy for accommodating an underpowered primary endpoint.
    Huque MF; Alosh M
    J Biopharm Stat; 2012; 22(1):160-79. PubMed ID: 22204533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical testing of multiple endpoints in group-sequential trials.
    Glimm E; Maurer W; Bretz F
    Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient method for accommodating potentially underpowered primary endpoints.
    Li J; Mehrotra DV
    Stat Med; 2008 Nov; 27(26):5377-91. PubMed ID: 18759248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method of balanced adjustment in testing co-primary endpoints.
    Kordzakhia G; Siddiqui O; Huque MF
    Stat Med; 2010 Aug; 29(19):2055-66. PubMed ID: 20683896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing multiplicity issues of a composite endpoint and its components in clinical trials.
    Huque MF; Alosh M; Bhore R
    J Biopharm Stat; 2011 Jul; 21(4):610-34. PubMed ID: 21516560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical considerations for the next generation of clinical trials.
    Wu W; Shi Q; Sargent DJ
    Semin Oncol; 2011 Aug; 38(4):598-604. PubMed ID: 21810519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of adaptive alpha allocation methods for strong control of the family-wise error rate.
    Li H; Sankoh AJ; D'Agostino RB
    Stat Med; 2013 Jan; 32(2):181-95. PubMed ID: 22806685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenge of multiple co-primary endpoints: a new approach.
    Chuang-Stein C; Stryszak P; Dmitrienko A; Offen W
    Stat Med; 2007 Mar; 26(6):1181-92. PubMed ID: 16927251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials.
    Lu Q; Tse SK; Chow SC
    J Biopharm Stat; 2010 Jul; 20(4):705-19. PubMed ID: 20496201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of trichotomous pharmaceutical endpoints.
    Berger VW; Durkalski VL
    J Biopharm Stat; 2005; 15(4):739-45. PubMed ID: 16022176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gatekeeping testing via adaptive alpha allocation.
    Li JD; Mehrotra DV
    Biom J; 2008 Oct; 50(5):704-15. PubMed ID: 18932133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2027-40. PubMed ID: 22729929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mixture gatekeeping procedure based on the Hommel test for clinical trial applications.
    Brechenmacher T; Xu J; Dmitrienko A; Tamhane AC
    J Biopharm Stat; 2011 Jul; 21(4):748-67. PubMed ID: 21516567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and analysis of group sequential clinical trials with multiple primary endpoints.
    Kosorok MR; Yuanjun S; DeMets DL
    Biometrics; 2004 Mar; 60(1):134-45. PubMed ID: 15032783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.